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Introduction . Skin giant neoplastic ulcers are a very serious diagnostic and therapeutic problem. The objective of this 
work was to present the experiences and strategies of our center concerning the treatment of this type of neoplastic ulcers. 
Material and methods . In this paper we present and analyze 15 cases of patients treated for giant ulcers. This represented 
0.4% of all patients treated surgically for skin cancer in our center (n = 3983). Ulcers in this group of patients were located 
within the head (n = 6), chest (n = 4), abdomen (n = 2), male genitals (n = 1) and lower limbs (n = 2).  
Results . Our observations indicate that the treatment of giant skin neoplastic ulcers (although they are relatively rare) is 
a major clinical challenge and requires individualized multidirectional diagnostic and therapeutic methods.
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Introduction
Skin ulcers are a very serious diagnostic and therapeutic pro-
blem, which may affect different groups of oncological pa-
tients. These diseases are classified as chronic wounds. Ulcers 
can be one of the symptoms of cancer, including skin cancer, 
soft tissue cancer and cancer metastases. They can also appear 
as complications of radio- or chemotherapy. The most com-
mon neoplastic ulcers are skin cancers, including basal-cell 
carcinoma (BCC), squamous-cell carcinoma (SCC) and melano-
mas. Among metastatic neoplastic ulcers, the most frequently 
described are metastases of breast cancer and reproductive 
organ cancer [1–3]. In the medical literature, neoplastic ulcers 
are called skin giant neoplastic ulcers, large cancer ulcers, as well 
as major cancer ulcers [4–7]. For the purpose of this study, the 
definition of “giant neoplastic ulcers” was adopted, understood 
as chronic defects in body integuments (of neoplastic origin) 
that require:
• extensive local plastic surgery with the help of skin and 
fasciocutaneous flaps or
• the use of skin grafts of split thickness to cover the resulting 
loss of body integuments, or 
• multiorgan or block resections.
It should be remembered that the surgeries of removing giant 
ulcers and supplementing the defects are associated with a high 
risk of complications. This is due to the need to perform extensive 
tissue resections and an increased risk of infection of the operated 
site due to the presence of multiple drug resistant bacterial flora. 
The aim of this paper is to present the experiences of our 
center in the diagnostics and treatment of skin giant neoplastic 
ulcers and the applied therapeutic strategies.
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Material and method
In the years 2012–2018, 3983 patients with skin cancers 
(n = 2885), melanoma (n = 726), sarcomas (n = 96) and single 
neoplastic metastases to body integuments (n = 276) were 
operated on in the Department of Oncological Surgery of 
the Medical University of Gdańsk (Tab. I). Among this group 
of patients in the CliniNet hospital IT system we were looking 
for patients who were treated due to giant neoplastic ulcers. 
We adopted the following search criteria:
• diagnosis of: skin cancers (C44.0–C44.7 according to ICD 
10), melanomas (C43–C43.8 according to ICD 10), sarcomas 
(C49–C49.9 according to ICD 10) and metastases of other 
skin cancers (C76–C76.8 according to ICD 10),
• procedures: radical excision of the skin lesion (86.4 ICD 9), 
stitching skin and subcutaneous tissue (86.5 according to 
ICD 9), free skin grafting (86.6 according to ICD 9), pedicled 
or free skin flap (86.7 according to ICD 9).
Based on the search results, 15 patients (0.4% of patients 
treated surgically with skin cancers) aged 20–80 years, in whom 
giant neoplastic ulcers were found, were qualified for further 
analysis. We excluded from the study patients with features 
of cancer spread and those who did not consent to surgical 
treatment. We obtained the consent of the local bioethics 
commission (KBN/180/2012) to conduct the study, and the 
patients qualified for this analysis gave their conscious written 
consent to participate in the study. 
Each patient qualified for the study was treated according 
to one diagnostic and therapeutic scheme in accordance with 
the guidelines of oncological treatment. The panel of experts 
qualifying for surgery and further oncological treatment inc-
luded specialists in oncological, plastic and urological surgery, 
laryngology, clinical oncology and radiotherapy. In the pre-
operative period, patients were examined in detail physically, 
computed tomography, chest radiography were performed 
and biological material for microbiological evaluation (tissue 
sample from the ulcer margins) was collected. The advance-
ment of the cancer process was assessed according to the TNM 
classification (8th edition) [8]. On the day preceding the surgery, 
ulcer swabs were taken for microbiological examination. Before 
the surgery, the planned surgical incision lines were marked, 
taking into account the extent of preparation of skin flaps and 
ulcer location. After ulcer resection within macroscopically 
healthy tissues, local reconstruction of the defect with the use 
of skin and fasciocutaneous flaps and skin grafts was started.
During difficult reconstructions, procedures in the team 
were performed with the participation of a plastic surgeon, 
urologist and laryngologist. In the analysis of patients operated 
on because of giant skin ulcers, we took into account the loca-
tion of an ulcer, postoperative pathomorphological result, the 
extent of resection and complications. In addition, we analyzed 
selected parameters from the postoperative period, such as 
the duration of the procedure and the length of hospital stay.
Results
The analysis of wound healing showed a proper healing by 
rapid growth in 14 patients. Only in 1 patient the presence of 
necrosis covering about 30% of grafted skin surface healed by 
granulation was observed. For the whole group of patients the 
surgery duration time was 60–120 minutes, and the average 
hospital stay was 10 days (4–28 days). 
Skin cancers
Detailed demographic and clinical characteristics of patients 
with ulcerated skin cancer are presented in Table II (n = 10). 
The average age of patients was 72 years (range: 48–91 years). 
Ulcers in this group of patients were located within the head 
(n = 5), chest (n = 3), abdomen (n = 1) and male genitals (n = 1). 
In histopathological evaluation only squamous-cell carcinomas 
(n = 10) were diagnosed with G1 (n = 1), G2 (n = 7) and G3 
(n = 2) malignancy. 
Skin melanomas
In the analyzed group of patients with giant neoplastic ulcers, 
two female patients with skin melanomas were described. 
The first one of them (at the age of 67) had a cheek ulcer. The 
cancer spread was excluded and the patient was qualified for 
resection of the lesion together with evaluation of the sentinel 
node. The ulcer was excised and the local skin plastic surgery 
was performed. In histopathological evaluation nodular me-
lanoma exulcerans (18 mm Breslow, Clark level V, mitotic index 
11/mm2) was described. Finally, the stage of tumor progression 
was described as pT4bN1(sn)M0. Due to the presence of ma-
croprojection in the guard node, cervical lymphadenectomy 
was performed in the lateral triangle of the neck. 
The second patient (76 years old) was diagnosed with 
ulcerated melanoma located on her back. The ulcer was exci-
sed and local plastic surgery was performed with the use of 
fasciocutaneous flaps. In histopathological evaluation nodular 
Table I . Patients with skin giant neoplastic ulcers treated in the years 2012-2018 in the Clinic of Oncological Surgery of the Medical University of Gdańsk
Type of neoplasm Number of patients (n = 3983) Patients with skin giant neoplastic ulcers (n = 15)
Skin cancer 2885 10 (0.35%)
Melanoma 726 2 (0.3%)
Sarcoma 96 2 (2.1%)
Cancer metastasis* 276 1 (0.36%)
* renal cancer metastasis
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melanoma exulcerans was diagnosed (13.5 mm Breslow, Clark 
level V, mitotic index 15/mm2). No metastases were found in 
the excised sentinel node marked with dye-isotope method 
from the left armpit. The stage of tumor progression was de-
scribed as pT4bN0M0. 
Sarcomas
In the analyzed clinical material 2 patients with giant ulcerated 
sarcomas were described. In the first of them (at the age of 
92) the extensive ulcer was located on the medial surface of 
the left thigh. The ulcer was excised and local skin plastic sur-
gery was performed with the use of fasciocutaneous flaps. In 
histopathological report undifferentiated pleomorphic sarcoma 
(high grade pT4NxMx) was described and R0 resection was 
achieved. In the second patient (aged 88 years) ulcerated 
tumor of the left knee was found. After the tumor resection, 
the histopathological examination described undifferentiated 
pleomorphic sarcoma and R0 resection was achieved. 
Single metastasis of kidney cancer to the skin 
An isolated metastasis of kidney cancer to the skin was found 
in one patient – a 73-year-old male whose kidney had been 
removed 22 years earlier due to cancer. In our center, the 
patient underwent surgery to remove a metastatic tumor to 
the skin located in the central part of the abdomen. The hi-
stopathological evaluation of excised skin ulcer confirmed the 
diagnosis of metastasis of clear-cell carcinoma of the kidney 
with R0 resection. 
With respect to the whole group, postoperative analysis 
of the results of pathomorphological examinations showed 
that in 14 patients radical resection (R0) was achieved. With 
only one person (with skin cancer) R1 resection was achieved. 
In the last case, the resection was performed again and full 
oncological radicalization was achieved.
In microbiological evaluation of ulcers, Gram-positive 
bacteria dominated among isolated bacteria, such as Staphy-
lococcus aureus, Staphylococcus epidermidis, Enterococus faecalis 
and streptococci, whereas among Gram-negative bacteria 
Escherichia coli, Pseudomonas spp. as well as Proteus mirabilis 
and Serratia marcensensens were found.
Discussion 
Giant neoplastic ulcers are a serious challenge for modern 
oncological surgery. In cancer patients, these are the most 
Table II . Detailed demographic and clinical characteristics of patients with ulcerated skin cancer treated in the years 2012–2018 in the Clinic of Oncological 
Surgery, Medical University of Gdańsk
Item Sex Age Location Microscopic type Participation 
of specialists
Excision range Type of plastic 
surgery 
Complications
1 M 56 External genital 
organs
Skin cancer, 
invasive, G2
Oncological 
surgeon, 
urologist
Male genital excision Urethral plastic 
surgery
Split thickness free 
skin graft
Not observed
2 M 79 Cheek Skin cancer, 
invasive, G2
Oncological 
surgeon, 
laryngologist
Parotid gland 
excision with 
superficial 
lobe; cervical 
lymphadenectomy** 
Local plastic 
surgery with skin 
flaps
Not observed
3 M 48 Chest Skin cancer, 
invasive, G2
Oncological 
surgeon
Excision Split thickness skin 
graft 
Partial necrosis 
of a graft with 
healing by 
granulation
4 M 79 Hairy skin of the 
head
Skin cancer, 
invasive, G3
Oncological 
surgeon, plastic 
surgeon
Excision, local plastic 
surgery 
Resection of one 
of the edges of 
the scar
Not observed
5 F 71 Hairy skin of the 
head
Skin cancer, 
invasive, G21
Oncological 
surgeon
Excision Local plastic 
surgery
Not observed
6 M 85 Abdomen Skin cancer, 
invasive, G2
Oncological 
surgeon
Excision Local plastic 
surgery
Not observed
7 F 91 Temple Skin cancer, 
invasive, G2
Oncological 
surgeon
Excision Local plastic 
surgery
Not observed
8 M 71 Back Skin cancer, 
invasive, G2
Oncological 
surgeon
Excision Local plastic 
surgery
Not observed
9 M 67 Hairless skin of the 
head
Skin cancer, 
invasive, G21
Oncological 
surgeon, plastic 
surgeon
Excision Local plastic 
surgery
Not observed
10 M 70 Chest Skin cancer, 
invasive, G2
Oncological 
surgeon
Excision Split thickness skin 
graft
Not observed
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common symptoms of a significant advancement of the di-
sease. In our material, giant skin ulcers occurred in about 0.4% 
of patients treated surgically for skin cancer. In the analyzed 
clinical material, extensive neoplastic ulcers occurred most 
frequently in patients with skin cancer, which corresponds 
to the literature data [4]. Therapeutic decisions were made 
within the framework of the panel of experts, which included 
specialists in various fields of surgical and conservative medi-
cine. The procedures were performed by oncological surgeons 
and doctors of other specialties, including plastic surgeons, 
laryngologists and urologists. 
The type of cancer plays an important role in the preope-
rative evaluation of patients with skin cancer. In patients with 
skin cancer, the local and regional lymph node status should 
be assessed first. In melanomas, sarcomas and ulcerated me-
tastases of other cancers, the presence of multiple metastases 
and spreading features of the disease (computed tomography, 
magnetic resonance imaging or PET) should be excluded in 
the first place [5]. The most important objective of surgical 
treatment of skin giant neoplastic ulcers is radical excision 
of the tumor. Therefore, in the preoperative diagnostics it is 
important to determine the stage of cancer advancement.
In our center, skin giant neoplastic ulcers in patients suf-
fering from skin cancer were most often located in the area 
of the head (including the face), then on the torso, and rarely 
on the external genital organs. These results also correspond 
to the literature data [4]. It was particularly difficult to operate 
on perineal ulcers, where in the patient – apart from extensive 
tissue defect after resection – it was necessary to perform an 
external genital amputation and local urethral plastic surgery. 
A difficult clinical case was also the removal of the ulcer of the 
cheek area with the infiltration of the superficial lobe of the 
parotid gland, where branches of the facial nerve had to be 
spared with special attention. 
It should be emphasized that in patients with giant neo-
plastic ulcers it is necessary to perform a radical R0 resection 
and in case of R1 resection the surgery should be considered. 
Healing of postoperative wounds in the observed patients 
was carried out by rapid growth, however, in one patient partial 
necrosis of a dermal graft was observed, which prolonged the 
period of full wound healing to several weeks. 
Surgical technique 
Apart from proper qualification for surgery, surgical techni-
que and experience of the team are important in the case of 
extensive neoplastic ulcers. One of the factors influencing 
difficult healing of the postoperative wound may be the local 
infection, which often accompanies ulcers. We used our own 
technique to isolate an ulcer from the rest of the surgical field 
using a surgical napkin soaked in disinfectant and placed on 
the ulcer. After isolating the ulcer, we disinfected the surgical 
field again. In order to achieve a good therapeutic effect, it 
is extremely important to plan surgical cuts in order to be 
able to perform a plastic surgery of the wound with skin and 
fasciocutaneous flaps or to perform split thickness skin graft 
(Figs. 1 and 2). 
Bacterial colonization of neoplastic ulcers 
Neoplastic ulcers are chronic wounds often colonized or infec-
ted with various microorganisms, which also makes surgical 
treatment difficult and may cause postoperative complica-
tions. There are favorable conditions for bacterial growth in 
cancer tissue: low oxygen concentration allows the growth of 
both anaerobic and aerobic bacteria. Intensified local angioge-
nesis leads to the formation of a network of small blood ves-
sels with endothelial defects, through which microorganisms 
spread in the tissue [9]. Disturbances of local immune response 
associated with the presence of cancer allow for uncontrolled 
Figure 1 . A giant neoplastic ulcer near the area of the left shoulder (a). Condition after excision and restoration of the left shoulder cavity with local 
plastic surgery of the grafted skin (b)
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proliferation of microorganisms. Proliferating bacteria also 
secrete pro-inflammatory factors, cytokines and chemokines, 
which may contribute to cancer progression [10]. Neoplastic 
ulcers are usually covered with necrotic tissues that contain 
nutrients used by bacteria. 
The microflora of neoplastic ulcers is also dependent on 
the area of the lesion in which the neoplasm is located – ulcers 
of the neck and head are more often colonized by Gram-posi-
tive bacteria (e.g. Streptococcus spp.) and anaerobes from the 
upper respiratory tract flora, whereas the area of the abdomen, 
rectum and genitourinary tract is dominated by Gram-negative 
bacteria (most often Klebsiella spp, Escherichia coli, Proteus spp., 
Pseudomonas aeruginosa) and also enterococci. Ulcers asso-
ciated with skin cancers are often colonized or infected with 
Staphylococcus aureus. It should be noted, however, that the 
presence of bacteria in a cancer ulcer does not always indicate 
infection. It is often a massive colonization, which does not 
require antibiotic therapy. 
In the case of the planned repair operation of large ulcers, 
microbiological diagnostics (cultures from the border of he-
althy tissues after the removal of superficial necrosis) is sug-
gested. Knowledge of the bacterial flora of ulceration may 
facilitate the initiation of appropriate antibiotic therapy in case 
of postoperative infection [11].
Prospects for the treatment of giant skin 
neoplastic ulcers
Progress in tissue engineering and regenerative medicine offer 
more and more possibilities for the reconstruction of defects 
caused by surgical skin removal. Hypothetical possibilities 
include the use of biomaterials as well as materials combined 
with various types of cells. Attempts are being made to use 
fibrin gels, collagen gels and other materials of high biocompa-
tibility and clinical safety. The materials are intended to provide 
temporary wound cover and promote the natural processes of 
tissue regeneration and reconstruction. This can be done by 
stimulating the migration and proliferation of skin cells (kerati-
nocytes, fibroblasts), adipose stem cells and other cells residing 
in the skin and subcutaneous tissue. These materials may also 
have an immunomodulatory effect, which may stimulate tissue 
regeneration, e.g. by polarization of macrophages (M1/M2) or 
anti-inflammatory effects. A number of scientific and clinical 
Figure 2 . A giant skin cancer with infiltration of the parotid gland (a). Postoperative condition with removal of the tumor with parotid gland and 
lymphedenectomy of the lateral triangle of the neck (b)
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studies on new biomaterials and therapies are currently being 
conducted around the world in order to achieve even greater 
efficiency and safety in the treatment of skin defects [12–14].
Conclusions
Giant skin ulcers occur mostly in the course of skin cancers, 
and are rarely caused by the metastasis of other cancers to 
the skin. Multidirectional activities with the participation of 
doctors of various specialties may be the basis for effective 
treatment of extensive ulcerations. Tissue engineering creates 
new opportunities for the treatment of giant ulcers and tissue 
defects, which in the future may be a chance for patients in 
whom conventional methods of treatment do not have the 
appropriate clinical effect. 
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